Skip to main content
Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.160
-0.030 (-2.52%)
Dec 20, 2024, 4:00 PM EST - Market closed

Accelerate Diagnostics Revenue

Accelerate Diagnostics had revenue of $2.98M in the quarter ending September 30, 2024, a decrease of -9.82%. This brings the company's revenue in the last twelve months to $11.91M, down -0.79% year-over-year. In the year 2023, Accelerate Diagnostics had annual revenue of $12.06M, down -5.43%.

Revenue (ttm)
$11.91M
Revenue Growth
-0.79%
P/S Ratio
2.01
Revenue / Employee
$88,873
Employees
134
Market Cap
29.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.06M-693.00K-5.43%
Dec 31, 202212.75M970.00K8.23%
Dec 31, 202111.78M617.00K5.53%
Dec 31, 202011.17M1.87M20.09%
Dec 31, 20199.30M3.63M63.97%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AXDX News

More News